Skip to main content

Andrea Guala

Andrea Guala is a post-doc researcher working in Cardiovascular Imaging analysis. After a PhD at the Politecnico of Turin (Italy) about modelling of the heart and large arteries, he moved to the Vall D’Hebron Institute of Research thanks to a Marie-Curie Post-Doctoral grant, starting on May 2016. From 2019 his work is supported by a Juan de la Cierva post-doctoral grant. His main research line relates to the developed of image analysis codes to assess biomarkers from multi-modality cardiovascular images and their evaluation as descriptors of aortic and heart diseases and as predictors of patients’ clinical evolution. As per September 2021, Andrea co-authored 39 peer-review scientific publications. Among them, he was first authors in papers published in the most important journals of cardiology, such the European Heart Journal, Circulation and JACC cardiovascular imaging. During his stay in Barcelona, Andrea’s work has been awarded by the Marie Sklodowska-Curie Acciones seal of excellence (2017), several travel grants to attend international conferences and a number of conference awards. He collaborates in a several projects funded by regional, national and European bodies and collaborates with many researchers from all over the world

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Andrea Guala

Institutions of which they are part

Main researcher
Cardiovascular Diseases
Vall Hebron Institut de Recerca

Andrea Guala is a post-doc researcher working in Cardiovascular Imaging analysis. After a PhD at the Politecnico of Turin (Italy) about modelling of the heart and large arteries, he moved to the Vall D’Hebron Institute of Research thanks to a Marie-Curie Post-Doctoral grant, starting on May 2016. From 2019 his work is supported by a Juan de la Cierva post-doctoral grant. His main research line relates to the developed of image analysis codes to assess biomarkers from multi-modality cardiovascular images and their evaluation as descriptors of aortic and heart diseases and as predictors of patients’ clinical evolution. As per September 2021, Andrea co-authored 39 peer-review scientific publications. Among them, he was first authors in papers published in the most important journals of cardiology, such the European Heart Journal, Circulation and JACC cardiovascular imaging. During his stay in Barcelona, Andrea’s work has been awarded by the Marie Sklodowska-Curie Acciones seal of excellence (2017), several travel grants to attend international conferences and a number of conference awards. He collaborates in a several projects funded by regional, national and European bodies and collaborates with many researchers from all over the world

.

Projects

CardioP3T: Nuevos biomarcadores de diagnóstico y pronóstico en patología cardíaca a partir de técnicas de imagen híbrida PET-RM

IP: Jose Fernando Rodríguez Palomares
Collaborators: Lydia Dux-Santoy Hurtado, Andrea Guala
Funding agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 138065.8
Reference: RTC2019-007280-1
Duration: 01/01/2020 - 31/12/2023

Ministerio de Ciencia

ANEURISMAS DE AORTA ASCENDENTE. PROGRESION DE LA DILATACION: ETIOPATOGENIA Y NUEVOS BIOMARCADORES DE IMAGEN PARA PREDECIR SU EVOLUCION

IP: Artur Evangelista Masip
Collaborators: Jose Fernando Rodríguez Palomares, Rafael Rodríguez Lecoq, Gisela Teixido Tura, Aroa Ruiz Muñoz, Hug Cuellar Calabria, Lydia Dux-Santoy Hurtado, Andrea Guala
Funding agency: Instituto de Salud Carlos III
Funding: 134310
Reference: PI17/00381
Duration: 01/01/2018 - 30/06/2022

'Innovative techniques for analysing the interaction between aortic valve dysfunction and aortic dilation

IP: Artur Evangelista Masip
Collaborators: Andrea Guala, Miriam Izquierdo Sans
Funding agency: EUROPEAN COMMISSION
Funding: 43560
Reference: INCOMED - FELLOW 5
Duration: 01/05/2016 - 28/02/2018

Related news

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

In total, different projects of six research groups will be promoted, focusing on precision medicine and advanced therapies.

The Cardiovascular Diseases and Neurovascular Diseases groups at VHIR will investigate new therapeutic strategies for heart failure, nanomedicine in stroke and the prevention of cardiovascular toxicity in the case of oncological treatments.

Related professionals

Sanz Tejo, Marta

Sanz Tejo, Marta

Research technician
Read more
Sergi Martí Beltran

Sergi Martí Beltran

Pneumology
Read more
Polo Figueres, Laura

Polo Figueres, Laura

Multidisciplinary Nursing Research Group
Read more
Paula Granado Martinez

Paula Granado Martinez

Predoctoral researcher
Biomedical Research in Melanoma
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.